Have a feature idea you'd love to see implemented?
Let us know!
IRD Opus Genetics Inc.
Price (delayed)
$1.27
Market cap
$33.27M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.54
Enterprise value
-$8.14M
Highlights
The quick ratio has grown by 40% YoY and by 20% from the previous quarter
Opus Genetics's equity has decreased by 12% QoQ but it has increased by 8% YoY
The company's net income has shrunk by 176% YoY and by 25% QoQ
The company's EPS has shrunk by 155% YoY and by 13% QoQ
Key stats
What are the main financial stats of IRD
Market
Valuations
Earnings
Shares outstanding
26.2M
Market cap
$33.27M
Enterprise value
-$8.14M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.81
Price to sales (P/S)
1.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.49
Revenue
$16.45M
EBIT
-$14.09M
EBITDA
-$14.09M
Free cash flow
-$11.46M
Per share
Balance sheet
Liquidity
EPS
-$0.54
Free cash flow per share
-$0.44
Book value per share
$1.57
Revenue per share
$0.64
TBVPS
$1.74
Total assets
$44.83M
Total liabilities
$4.2M
Debt
$0
Equity
$40.64M
Working capital
$40.64M
Debt to equity
0
Current ratio
10.68
Quick ratio
10.41
Net debt/EBITDA
2.94
Margins
Efficiency
Dividend
EBITDA margin
-85.7%
Gross margin
100%
Net margin
-85.7%
Operating margin
-91.7%
Return on assets
-27.5%
Return on equity
-30.2%
Return on invested capital
-1,032.5%
Return on capital employed
-34.7%
Return on sales
-85.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRD stock price
How has the Opus Genetics stock price performed over time
Intraday
-4.51%
1 week
8.55%
1 month
-3.05%
1 year
-54.8%
YTD
-57.81%
QTD
-3.05%
Financial performance
How have Opus Genetics's revenue and profit performed over time
Revenue
$16.45M
Gross profit
$16.45M
Operating income
-$15.08M
Net income
-$14.11M
Gross margin
100%
Net margin
-85.7%
The operating income has plunged by 183% YoY and by 24% from the previous quarter
The company's net income has shrunk by 176% YoY and by 25% QoQ
The revenue has dropped by 64% year-on-year and by 13% since the previous quarter
IRD's gross profit has shrunk by 64% YoY and by 13% QoQ
Growth
What is Opus Genetics's growth rate over time
Valuation
What is Opus Genetics stock price valuation
P/E
N/A
P/B
0.81
P/S
1.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.49
The company's EPS has shrunk by 155% YoY and by 13% QoQ
The P/B is 65% below the 5-year quarterly average of 2.4 and 29% below the last 4 quarters average of 1.2
Opus Genetics's equity has decreased by 12% QoQ but it has increased by 8% YoY
The revenue has dropped by 64% year-on-year and by 13% since the previous quarter
IRD's P/S is 13% below its last 4 quarters average of 2.4
Efficiency
How efficient is Opus Genetics business performance
IRD's ROA has plunged by 156% YoY and by 24% from the previous quarter
Opus Genetics's return on equity has shrunk by 156% YoY and by 23% QoQ
The ROIC has shrunk by 122% YoY but it rose by 9% QoQ
The company's return on sales fell by 44% QoQ
Dividends
What is IRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRD.
Financial health
How did Opus Genetics financials performed over time
The current ratio has increased by 42% year-on-year and by 19% since the previous quarter
The quick ratio has grown by 40% YoY and by 20% from the previous quarter
Opus Genetics's debt is 100% lower than its equity
Opus Genetics's equity has decreased by 12% QoQ but it has increased by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.